STEPHEN RENZI: Open Payments
NPI 1760456214 · TROY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 141 payments from 26 companies in 2025. Trend: 2023 $2,163 · 2024 $2,275 · 2025 $2,156
Food & beverage: $2,149Education: $7
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 33 | $415 |
| ABBVIE INC. | 21 | $290 |
| AstraZeneca Pharmaceuticals LP | 10 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $181 |
| Lilly USA, LLC | 12 | $178 |
| PFIZER INC. | 13 | $155 |
| Verona Pharma, Inc. | 3 | $78 |
| Lundbeck LLC | 3 | $77 |
| Eisai Inc. | 3 | $64 |
| Kowa Pharmaceuticals America, Inc. | 4 | $64 |
Products named: PURIFIED CORTROPHIN GEL, AIRSUPRA, CAPLYTA, VRAYLAR, NURTEC ODT, MOUNJARO, QULIPTA, Leqembi.
Industry payments across PA — which companies pay providers there.
